A study from The Netherlands (Riphagen, 2020) found that after 8.5 years of follow-up of an older cohort (median baseline age=65), a doubling of baseline MMA levels was associated with an increased risk of mortality (HR 11.48, CI 3.3239.64)
FDA: Not approved as a drug or dietary supplement in the United States
PubMed PMID 30915550 review of BPC-157 in musculoskeletal soft-tissue research, emphasizing that most evidence comes from small-animal models
Older Adults As we age, our ability to absorb B12 from food sources decreases
This research highlights considerable therapeutic potential, particularly in tissue repair, gastrointestinal protection and inflammation modulation
BPC-157 is highly soluble and will usually dissolve on its own within minutes